OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
5.19
+0.09 (1.76%)
May 29, 2026, 4:00 PM EDT - Market closed
OptimizeRx Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 6.84 | 5.13 | -20.11 | -17.57 | -11.44 | 0.38 |
Depreciation & Amortization | 4.3 | 4.33 | 4.33 | 2.4 | 2.02 | 1.97 |
Stock-Based Compensation | 7.23 | 6.96 | 11.47 | 13.72 | 15.75 | 5.49 |
Other Adjustments | 1.66 | 1.48 | 8.53 | 9.76 | 0.36 | 0.08 |
Change in Receivables | 0.73 | 0.46 | -2.17 | -8.71 | 2.28 | -6.99 |
Changes in Accounts Payable | -1.1 | -2.49 | -0.53 | 0.2 | 0.56 | -0.6 |
Changes in Accrued Expenses | -5.47 | 3.37 | 1.05 | 1.3 | -0.3 | 0.48 |
Changes in Income Taxes Payable | -0.76 | -1.07 | - | - | - | - |
Changes in Unearned Revenue | 0.16 | 0.03 | 0.3 | -0.07 | -1.23 | 1.1 |
Changes in Other Operating Activities | 1.05 | 0.51 | 2.01 | -8.27 | 2.65 | -1.18 |
Operating Cash Flow | 7.3 | 18.72 | 4.89 | -7.24 | 10.65 | 0.73 |
Operating Cash Flow Growth | 13.35% | 282.80% | - | - | 1367.43% | - |
Capital Expenditures | -0.05 | -0.06 | -0.11 | -0.09 | -0.08 | -0.1 |
Sale of Property, Plant & Equipment | - | - | - | 0.01 | - | - |
Purchases of Intangible Assets | -0.05 | 0.13 | -0.34 | -0.78 | -0.16 | -0.39 |
Purchases of Investments | - | - | - | -162.78 | -55.93 | - |
Proceeds from Sale of Investments | - | - | - | 218.71 | - | - |
Payments for Business Acquisitions | - | - | - | -82.95 | -2 | - |
Proceeds from Business Divestments | - | - | - | 2.54 | - | - |
Investing Cash Flow | -0.08 | 0.07 | -0.45 | -25.34 | -58.18 | -0.49 |
Long-Term Debt Issued | - | - | - | 37.73 | - | - |
Long-Term Debt Repaid | -10.19 | -8 | -4 | -1.71 | - | - |
Net Long-Term Debt Issued (Repaid) | -10.19 | -8 | -4 | 36.02 | - | - |
Issuance of Common Stock | 0.01 | 0.35 | - | -0.28 | 1.07 | 75.54 |
Repurchase of Common Stock | -1.08 | -1.15 | -0.91 | -7.52 | -20.02 | - |
Net Common Stock Issued (Repurchased) | -1.07 | -0.8 | -0.91 | -7.8 | -18.95 | 75.54 |
Other Financing Activities | - | - | - | - | - | -1.61 |
Financing Cash Flow | -5.51 | -8.8 | -4.91 | 28.22 | -18.95 | 73.93 |
Net Cash Flow | 3.6 | 9.99 | -0.47 | -4.36 | -66.47 | 74.17 |
Free Cash Flow | 7.24 | 18.66 | 4.78 | -7.33 | 10.57 | 0.63 |
Free Cash Flow Growth | -61.17% | 290.56% | - | - | 1589.76% | - |
FCF Margin | 6.75% | 17.05% | 5.19% | -10.24% | 16.93% | 1.02% |
Free Cash Flow Per Share | 0.38 | 0.98 | 0.26 | -0.43 | 0.59 | 0.04 |
Levered Free Cash Flow | -7.55 | 1.76 | -17.05 | 13.93 | -7.82 | 2.05 |
Unlevered Free Cash Flow | 16.84 | 19.38 | -6.14 | -38.9 | -8.67 | 2.03 |